MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2011

Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).

Cantón Rafael, Loza Elena, Aznar Javier, Calvo Jorge, Cercenado Emilia, Cisterna Ramón, Romo Fernando González, Hontangas José Luis López, Calvo Carmen Rubio, Barrenechea Ana Isabel Suárez, Tubau Fe, Weber Irene, Yuste Patricia, Cavanillas Rafael, SMART-Spain Working Group

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

INTRODUCTION

The SMART (Study for Monitoring Antimicrobial Resistance Trends) surveillance study records the antimicrobial susceptibility of Gram-negative bacilli obtain from intraabdominal infections with special focus in isolates with extended spectrum β-lactamases (ESBLs).

MATERIAL AND

METHODS

The antimicrobial susceptibility of 8,869 isolates was analyzed by microdilution during the SMART study performed in Spain from 2002 to 2010. Isolates were recovered in 16 centres.

RESULTS

Escherichia coli was the most prevalent pathogen (60.9% from intraabdominal infections acquired in the community and 49.9% in those from nosocomial origin) followed by Klebsiella pneumoniae (8.9% vs 9.2%). Pseudomonas aeruginosa was more common in intraabdominal infections from nosocomial origin (5.6% community and 8.6% nosocomial). Frequency of ESBL-producing isolates was: E. coli, 8.7%; K. pneumoniae, 8.4%; Klebsiella oxytoca, 1.4%; and Proteus mirabilis, 1.6%. Overall, ESBL-producing isolates were more frequently isolated from elderly patients (6.8% >60 years). Ertapenem and meropenem were the most active antimicrobials (susceptibility range with EUCAST criteria, 89.0-100%) when considering all Enterobacteriaceae isolates and also against ESBL producers (95.5-100%). Susceptibility of amoxicillin/clavulanic acid and piperacillin/tazobactam was lower, particularly among ESBL-producing isolates. Nevertheless, ertapenem maintained a good activity (susceptibility >95%) in ESBL-producers that were resistant to amoxicillin/clavulanic acid, piperacillin/tazobactam or fluoroquinolones.

CONCLUSIONS

Antimicrobial susceptibility data from the SMART-Spain study reinforce current therapeutic guidelines of intraabdominal infections that include ertapenem as the empirical choice for treatment. This is also supported by the high frequency of ESBL-producers in our geographic area.

Для цитирования: Cantón Rafael, Loza Elena, Aznar Javier, Calvo Jorge, Cercenado Emilia, Cisterna Ramón, Romo Fernando González, Hontangas José Luis López, Calvo Carmen Rubio, Barrenechea Ana Isabel Suárez, Tubau Fe, Weber Irene, Yuste Patricia, Cavanillas Rafael, SMART-Spain Working Group. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.